FERRING PHARMACEUTICALS A/S

CVR 16313440 · Public limited company (A/S) · Active · Low risk

FERRING PHARMACEUTICALS A/S is a Public limited company (A/S), founded on , based in Kastrup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 315.2m and a net result of DKK 49.0m. CEO: Kim Fonager Jensen, Jesper Thomsen, Ingbritt Tolstrup Birk.

Bankruptcy risk for FERRING PHARMACEUTICALS A/S

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 0% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO changes in the last year2+ · bankruptcy rate 18.5%2.1×
Time since new CEO0.5–1 yrs · bankruptcy rate 15.6%1.8×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Reporting classReporting class C, stor virksomhed · bankruptcy rate 1.1%0.13×
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Employees (latest year)100+ · bankruptcy rate 2.3%0.27×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Gross profit growth0%–10% · bankruptcy rate 3.5%0.39×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
16313440
Status
Active
Company type
Public limited company (A/S)
Founded
(34 years)
Address
Amager Strandvej 405
2770 Kastrup
Municipality
Tårnby
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 500k
Employees
556 (2018)
Auditor
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late4 of 31
Missing annual reportNo
Negative equityNo
Equity ratio47.0%
Current ratio145%
Moves (last 2 years)0
CEO changes in total25
CEO's previous bankruptcies0
Other companies at the address2
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
RevenueDKK 1.7bnDKK 1.7bn
Gross profitDKK 824.4mDKK 801.1m
Net profitDKK 49.0mDKK 76.9m
EquityDKK 315.2mDKK 266.2m
Total assetsDKK 671.1mDKK 554.5m
CashDKK 0–
Short-term debtDKK 314.5m–
Tax owedDKK 39.9m–
Avg. employees577–

Latest annual report: Reporting class C, stor virksomhed · auditor's statement: Revisionspåtegning · DeloitteStatsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025181
1 Jan 2024 – 31 Dec 2024126
1 Jan 2023 – 31 Dec 2023181
1 Jan 2022 – 31 Dec 2022160
1 Jan 2021 – 31 Dec 2021115
1 Jan 2020 – 31 Dec 202081
1 Jan 2019 – 31 Dec 2019232 Late
1 Jan 2018 – 31 Dec 2018105
1 Jan 2017 – 31 Dec 2017107
1 Jan 2016 – 31 Dec 201683
1 Jan 2015 – 31 Dec 201591
1 Jan 2014 – 31 Dec 201491
1 Jan 2013 – 31 Dec 2013116
1 Jan 2012 – 31 Dec 2012105
1 Jan 2011 – 31 Dec 2011131
1 Jan 2010 – 31 Dec 2010172
1 Jan 2009 – 31 Dec 2009173
1 Jan 2008 – 31 Dec 2008160
1 Jan 2007 – 31 Dec 2007169
1 Jan 2006 – 31 Dec 2006137

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOKim Fonager JensenCurrent
CEOJesper ThomsenCurrent
CEOIngbritt Tolstrup BirkCurrent
CEOMats Lundwall
CEOPer Emil Hasselbalch Stakemann
CEOEva Wolf Paulsen
CEOÅke Stefan Warin
CEOChristiaan Paul Thomas
CEOOle Kjerulf-Jensen
CEOPascal Rene Olivier Danglas
CEOMarianne Kock
CEOBolette Wildt
CEOKlaus Grønbæk Jakobsen
CEOLene Melchiorsen
CEOAnette Hedegaard Østergaard
CEOTamara Vukmirovic
BoardDag Frederik Arfst PaulsenCurrent
BoardMarianne KockCurrent
BoardJean-Frederic PaulsenCurrent
BoardHans Christian Galst
BoardUlf Svejgaard Poulsen
BoardPer Emil Hasselbalch Stakemann
BoardEva Wolf Paulsen
BoardMats Lundwall
BoardChristiaan Paul Thomas
BoardJeffrey David Hobbs
BoardJean Louis Junien
BoardPascal Rene Olivier Danglas
BoardOle Kjerulf-Jensen
BoardPer Gunnar Falk
BoardMarianne Kock
BoardPer Gunnar Falk
BoardArmin Metzger
BoardPierre Yves Berclaz
BoardJesper Thomsen
Owner (100%)Ferring B.V.Current
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
AuditorErik Tronborg Andersen
AuditorJohn Voigt
AuditorPRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderMEDIMEX ApSCurrent
FounderApS KBIL 9 NR. 1008Current
FounderVX 20.181 ApSCurrent

The CEOs' other companies

Kim Fonager Jensen – 1 other companies

Per Emil Hasselbalch Stakemann – 45 other companies, of which 45 bankrupt

Ole Kjerulf-Jensen – 23 other companies

Marianne Kock – 6 other companies

Bolette Wildt – 1 other companies

Tamara Vukmirovic – 1 other companies

Address history (3 moves)

Amager Strandvej 405, 2770 Kastrup
Amager Strandvej 405, 2770 Kastrup
Kay Fiskers Plads 11, 2300 København S
Borups Alle 177, 2400 København NV

Former names

FERRING PHARMACEUTICALS A/S – now
FERRING NORDIC PHARMACEUTICALS A/S –
A/S PSE 38 NR. 1587 –

Employees per year

Number of employees at FERRING PHARMACEUTICALS A/S per year2895782011: 29220112012: 31120122013: 46920132014: 49620142015: 49420152016: 54120162017: 57820172018: 5562018

Other companies at the same address

Similar companies in Tårnby

Questions and answers about FERRING PHARMACEUTICALS A/S

Has FERRING PHARMACEUTICALS A/S gone bankrupt?

No, FERRING PHARMACEUTICALS A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of FERRING PHARMACEUTICALS A/S?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of FERRING PHARMACEUTICALS A/S?

Kim Fonager Jensen, Jesper Thomsen, Ingbritt Tolstrup Birk are the CEOs of FERRING PHARMACEUTICALS A/S.

Who is the auditor of FERRING PHARMACEUTICALS A/S?

FERRING PHARMACEUTICALS A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was FERRING PHARMACEUTICALS A/S founded?

FERRING PHARMACEUTICALS A/S was founded on 1 August 1992.

What is the equity of FERRING PHARMACEUTICALS A/S?

Equity was DKK 315.2m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.